Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
919
JPY
|
-1.39%
|
|
+1.66%
|
+16.33%
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
10,531
|
8,596
|
9,327
|
10,002
|
8,883
|
11,278
|
Enterprise Value (EV)
1 |
22,414
|
21,750
|
23,131
|
19,346
|
19,802
|
27,073
|
P/E ratio
|
70.7
x
|
296
x
|
81.1
x
|
17.4
x
|
28.1
x
|
130
x
|
Yield
|
1.22%
|
1.5%
|
1.38%
|
1.29%
|
1.45%
|
1.22%
|
Capitalization / Revenue
|
0.13
x
|
0.1
x
|
0.1
x
|
0.12
x
|
0.11
x
|
0.13
x
|
EV / Revenue
|
0.29
x
|
0.26
x
|
0.26
x
|
0.23
x
|
0.24
x
|
0.31
x
|
EV / EBITDA
|
12.2
x
|
12.8
x
|
11.3
x
|
10.7
x
|
10.1
x
|
17.1
x
|
EV / FCF
|
-54.6
x
|
-36.3
x
|
-22.4
x
|
18.6
x
|
-19.4
x
|
-7.22
x
|
FCF Yield
|
-1.83%
|
-2.76%
|
-4.46%
|
5.38%
|
-5.17%
|
-13.8%
|
Price to Book
|
1.26
x
|
1.04
x
|
1.14
x
|
1.16
x
|
1.01
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
13,784
|
13,784
|
13,784
|
13,784
|
13,793
|
13,804
|
Reference price
2 |
764.0
|
623.7
|
676.7
|
725.7
|
644.0
|
817.0
|
Announcement Date
|
8/9/18
|
8/8/19
|
8/12/20
|
8/11/21
|
8/10/22
|
8/9/23
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
78,482
|
84,649
|
89,304
|
83,240
|
82,905
|
87,481
|
EBITDA
1 |
1,830
|
1,693
|
2,041
|
1,812
|
1,952
|
1,579
|
EBIT
1 |
752
|
414
|
815
|
641
|
748
|
300
|
Operating Margin
|
0.96%
|
0.49%
|
0.91%
|
0.77%
|
0.9%
|
0.34%
|
Earnings before Tax (EBT)
1 |
414
|
552
|
452
|
973
|
429
|
175
|
Net income
1 |
149
|
29
|
115
|
574
|
316
|
87
|
Net margin
|
0.19%
|
0.03%
|
0.13%
|
0.69%
|
0.38%
|
0.1%
|
EPS
2 |
10.81
|
2.104
|
8.343
|
41.64
|
22.92
|
6.304
|
Free Cash Flow
1 |
-410.9
|
-599.2
|
-1,031
|
1,041
|
-1,023
|
-3,749
|
FCF margin
|
-0.52%
|
-0.71%
|
-1.15%
|
1.25%
|
-1.23%
|
-4.29%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
57.44%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
181.34%
|
-
|
-
|
Dividend per Share
2 |
9.333
|
9.333
|
9.333
|
9.333
|
9.340
|
10.00
|
Announcement Date
|
8/9/18
|
8/8/19
|
8/12/20
|
8/11/21
|
8/10/22
|
8/9/23
|
Fiscal Period: May |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
45,050
|
42,571
|
41,865
|
20,655
|
21,496
|
42,952
|
22,605
|
23,985
|
47,813
|
24,303
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
138
|
261
|
266
|
143
|
72
|
334
|
6
|
227
|
681
|
241
|
Operating Margin
|
0.31%
|
0.61%
|
0.64%
|
0.69%
|
0.33%
|
0.78%
|
0.03%
|
0.95%
|
1.42%
|
0.99%
|
Earnings before Tax (EBT)
1 |
-156
|
764
|
331
|
148
|
76
|
384
|
-32
|
184
|
595
|
237
|
Net income
1 |
-188
|
396
|
177
|
90
|
30
|
224
|
-21
|
93
|
328
|
147
|
Net margin
|
-0.42%
|
0.93%
|
0.42%
|
0.44%
|
0.14%
|
0.52%
|
-0.09%
|
0.39%
|
0.69%
|
0.6%
|
EPS
2 |
-13.69
|
28.76
|
12.87
|
6.520
|
2.240
|
16.28
|
-1.560
|
6.750
|
23.77
|
10.65
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/20/19
|
12/18/20
|
12/17/21
|
3/18/22
|
9/16/22
|
12/16/22
|
3/17/23
|
9/20/23
|
12/20/23
|
3/19/24
|
Fiscal Period: May |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
11,883
|
13,154
|
13,804
|
9,344
|
10,919
|
15,795
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.493
x
|
7.77
x
|
6.763
x
|
5.157
x
|
5.594
x
|
10
x
|
Free Cash Flow
1 |
-411
|
-599
|
-1,031
|
1,041
|
-1,023
|
-3,749
|
ROE (net income / shareholders' equity)
|
1.7%
|
2.24%
|
1.23%
|
6.85%
|
3.72%
|
1.11%
|
ROA (Net income/ Total Assets)
|
1.48%
|
0.75%
|
1.4%
|
1.07%
|
1.17%
|
0.44%
|
Assets
1 |
10,040
|
3,860
|
8,186
|
53,690
|
26,937
|
19,590
|
Book Value Per Share
2 |
606.0
|
600.0
|
596.0
|
626.0
|
638.0
|
632.0
|
Cash Flow per Share
2 |
116.0
|
133.0
|
110.0
|
193.0
|
214.0
|
168.0
|
Capex
1 |
1,672
|
2,040
|
2,301
|
2,113
|
1,884
|
2,036
|
Capex / Sales
|
2.13%
|
2.41%
|
2.58%
|
2.54%
|
2.27%
|
2.33%
|
Announcement Date
|
8/9/18
|
8/8/19
|
8/12/20
|
8/11/21
|
8/10/22
|
8/9/23
|
|
1st Jan change
|
Capi.
|
---|
| +16.33% | 80.64M | | -32.21% | 15.27B | | -31.97% | 10.84B | | -30.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -0.88% | 4.71B | | +52.19% | 4.29B | | -12.31% | 3.61B | | -14.86% | 3.33B |
Other Drug Retailers
|